"LARGO, Florida, March 29, 2011 (LifeSiteNews.com) – Pepsico, Kraft Foods, Campbell Soup, Solae and Nestlé are among the corporations partnered with a biotech company found using aborted fetal cell lines to test food flavor enhancers.
The internationally recognized biotech company, Senomyx, boasts innovation and success in “flavour programs” designed to reduce MSG, sugar and salt in food and beverage products. Senomyx notes their collaborators provide them research and development funding plus royalties on sales of products using their flavor ingredients.
Pro-life watchdog group, Children of God for Life (CGL), has called upon the public to target the major corporations in a boycott, unless the company ceases to use aborted fetal cell lines in their product testing.
“Using isolated human taste receptors,” the Senomyx website claims, “we created proprietary taste receptor-based assay systems that provide a biochemical or electronic readout when a flavor ingredient interacts with the receptor.”
“What they do not tell the public is that they are using HEK 293 – human embryonic kidney cells taken from an electively aborted baby to produce those receptors,” stated Debi Vinnedge, Executive Director for CGL, the watch dog group that has been monitoring the use of aborted fetal material in medical products and cosmetics for years."
Lynn Stratton, freelance writer and independent investigative reporter based in the U.S. sheds some further light on the activities of Senomyx, including its collaborating companies, i.e. Nestle, Cadbury, Tropicana, Campbell Soup and others, here
And as she further points out, it's all about making money:
And why is Senomyx collaborating with the largest companies on the planet? From an annual report dated February of this year: "Our current collaboration agreements provide that we will receive royalties of up to 4% on our collaborators' sales of retail and food service products, and in some cases higher on our collaborators' sales of ingredient supplies containing our flavor ingredients." I recommend taking a look at that document (a link follows this article), especially Page 5, where you'll see that Senomyx has noted that worldwide sales of products that might potentially include their products are in the hundreds of billions. So 4% of that is, let's see . . . a lot.